Can Low LSD Doses Address Alzheimer’s Disease?

Eleusis Is Investigating Anti-Inflammatory Properties Of Psychedelics

 
• By Sten Stovall
  
LSD
Eleusis Is testing low-dose lysergic acid diethylamide for AD • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip